HPC Biosciences Ltd. - Research Center

---

Results

• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 21	Mar ' 20	Mar ' 19	Mar ' 18	Mar ' 17

Sources of funds

Owner's fund

Equity share capital

15.96

15.96

15.96

15.96

15.96

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

16.89

15.72

15.38

14.83

14.63

Loan funds

Secured loans

-

-

-

-

-

Unsecured loans

-

-

-

-

-

Total

32.85

31.68

31.34

30.79

30.59

Uses of funds

Fixed assets

Gross block

12.35

12.35

12.35

12.35

12.35

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

9.28

8.77

8.16

-

6.60

Net block

3.07

3.58

4.19

12.35

5.75

Capital work-in-progress

-

-

-

-

-

Investments

0.30

0.30

0.30

0.30

0.30

Net current assets

Current assets, loans & advances

29.76

28.25

27.41

26.05

24.95

Less : current liabilities & provisions

0.28

0.46

0.56

0.47

0.40

Total net current assets

29.48

27.80

26.85

25.58

24.54

Miscellaneous expenses not written

-

-

-

-

-

Total

32.85

31.68

31.34

38.23

30.59

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

1596.00

1596.00

1596.00

1596.00

1596.00